Topical Skincare Products Recalled for Improper Storage Conditions
Family Dollar Stores is recalling three topical skincare products distributed nationwide due to storage condition violations in manufacturing.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: This is an FDA Class II recall with no reported illnesses or injuries. The hazard—improper storage affecting product integrity—has not resulted in documented harm. Per the rubric, this qualifies as a risk-of-harm product without reported injury, warranting a High severity score of 3.
Plain-English summary
Family Dollar Stores is recalling three topical skincare products: St. Ives Blackhead Clearing Green Tea Scrub (6 oz, SKU 2007787), Ambi Exfoliating Wash (5 oz, SKU 2097153), and CC Blackhead Scrub (5 oz, SKU 2032021).
These products were held outside appropriate storage temperature conditions during distribution, which violates Current Good Manufacturing Practices (CGMP) standards.
The affected products were distributed nationwide to Family Dollar Stores between April 30, 2022, and June 10, 2022. Consumers who purchased these products during this period may have received affected units.
Consumers who have purchased these products should stop using them. For questions about affected products or this recall, consumers may contact Family Dollar Stores or the FDA.
The recalled product
- Product
- ST IVES BLKHD CLRNG GREEN TEA SCRUB 6 OZ SKU 2007787 AMBI EXFOLIATING WASH 5 OZ SKU 2097153 CC BLACKHEAD SCRUB 5 OZ SKU 2032021 distributed to specific Family Dollar Stores 04/30/2022 through 06/10/2022.
- Manufacturer
- Family Dollar Stores, Llc.
- Category
- Drug — Topical Skincare
- Hazard
- improper-storage
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (3)
- SKUs: 2007787
- 2097153
- 2032021
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27